Literature DB >> 2210672

Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis.

B A Runyon1.   

Abstract

Spontaneous bacterial peritonitis is diagnosed when (a) the ascitic fluid culture is positive, (b) the ascitic fluid neutrophil count is greater than or equal to 250 cells/mm3 and (c) there is no evident intraabdominal surgically treatable source for infection. Few details are available regarding the variant of ascitic fluid infection in which the culture grows bacteria (pure growth of a single type of organism), but the neutrophil count is less than 250 cells/mm3. In this prospective study of 138 episodes of culture-positive spontaneously infected ascites detected in 105 patients, 44 (31.9%) were episodes of "monomicrobial nonneutrocytic bacterascites" compared with 94 (68.1%) episodes of spontaneous bacterial peritonitis. Seventeen patients had both types of infection. The infection-related mortality and hospitalization mortality were similar between the two groups. Patients with bacterascites appeared to have less severe liver disease. In 62% of bacterascites episodes in which a second paracentesis was performed before any treatment the fluid spontaneously became sterile without development of ascitic fluid neutrocytosis. Thirty-eight percent of patients with bacterascites (who underwent a second paracentesis before treatment was started) progressed to spontaneous bacterial peritonitis--sometimes within a few hours. The concentration of the chemoattractant C5a was not decreased in the ascitic fluid of the bacterascites patients; this excludes ascitic fluid C5a deficiency as the explanation of the lack of neutrocytosis. Monomicrobial nonneutrocytic bacterascites is a common variant of ascitic fluid infection that may resolve without treatment or may progress to spontaneous bacterial peritonitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210672     DOI: 10.1002/hep.1840120415

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

Review 1.  New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Authors:  Z Younes; D A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2000-08

2.  Early events in spontaneous bacterial peritonitis.

Authors:  B A Runyon
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Characterisation of bacteria in ascites--reporting the potential of culture-independent, molecular analysis.

Authors:  G B Rogers; L E Russell; P G Preston; P Marsh; J E Collins; J Saunders; J Sutton; D Fine; K D Bruce; M Wright
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-18       Impact factor: 3.267

4.  Prevalence and risk factors for unsuspected spontaneous ascitic fluid infection in cirrhotics undergoing therapeutic paracentesis in an outpatient clinic.

Authors:  Pazhanivel Mohan; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2011-09-29

5.  Hepatobiliary quiz-7 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-09

6.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 7.  Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver.

Authors:  Philipp Lutz; Hans Dieter Nischalke; Christian P Strassburg; Ulrich Spengler
Journal:  World J Hepatol       Date:  2015-03-27

8.  Bacterial growth and antibiotic resistance patterns in cirrhotic ascites.

Authors:  Jose D Debes; Daniel Beisang; Paola Ricci
Journal:  Infection       Date:  2017-06-12       Impact factor: 3.553

9.  Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease.

Authors:  Micaela Brandolini; Marta Corbella; Annalisa De Silvestri; Carmine Tinelli; Giulia Albonico; Riccardo Albertini; Serena Ludovisi; Raffaele Bruno; Piero Marone; Lorenzo Minoli; Elena Seminari
Journal:  Infection       Date:  2015-05-15       Impact factor: 3.553

10.  Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection.

Authors:  J Such; D J Hillebrand; C Guarner; L Berk; P Zapater; J Westengard; C Peralta; G Soriano; J Pappas; B A Runyon
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.